Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.
Israel to allow international force into Gaza, Israeli official says
Saudi Arabia reaffirms right to defend its security against drone attacks
Philippines' Marcos puts anti-graft campaign at centre of address to Congress
French police arrest man after knife attack in Paris
France and Spain race to curb wildfires before new heatwave arrives
